Investigation into RUNX1's biological impact on CRC progression entailed generating cell lines with stable ectopic overexpression and knockdown of RUNX1, through transfection of F0 and F3 cells with a RUNX1-overexpressing vector or a specific shRNA. The gene discussed is RUNX1; the disease is colorectal carcinoma.